NCT Number: NCT00343590
Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study
The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in a participant with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.
Looking for future studies?
Notify MeKey information
Conditions
Age range
25 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Logan College of Chiropractic, Chesterfield, Missouri, United States
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)
Exclusion criteria
1)visual or vestibular condition that would affect balance; 2) Non-Ms related systemic illness that would have an adverse effect on balance; 3) Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes; 4) Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates; 5) Acute thrombosis; 6) Severe migraine, epilepsy; 7) Serious cardiovascular disease, wearing a pacemaker; Any Spinal manipulation within 48 hours; 8) Acute disc herniation, discopathy or spondylolysis; 9) Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance; 10) Any implanted device or prosthesis or intrauterine IUD type of device; 11) Pregnancy
Treatment and study plan
Primary outcomes
-
NeuroCom Balance Master
-
SF-EMG Nerve conduction velocity test
-
Berg balance score
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Logan College of Chiropractic
Other
Registry information
Important dates
- Study start
- 2006
- Primary completion
- 2006
- Study completion
- 2006
- First posted
- Jun 23, 2006
- Registry last updated
- Oct 17, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
NCT04721717
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Birmingham, Alabama, United States
View Trial DetailsClinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients.
NCT05835622
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Saint-Genis-Laval, Auvergne-Rhône-Alpes, France
View Trial DetailsThis is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
NCT03599245
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Buenos Aires, Argentina
View Trial DetailsThe CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis
NCT07840924
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Arnhem, Netherlands
View Trial Details